NFKB1 and ovarian carcinoma: Indeed, treatment of OVCAR8-NUAK1KO spheroids with the IKK inhibitor BAY 11-7082 increased ROS levels, which is consistent with a recent report that NF-κB-associated expression of antioxidant genes protects ovarian cancer cells from oxidative stress55.